<DOC>
	<DOCNO>NCT01877902</DOCNO>
	<brief_summary>STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM</brief_summary>
	<brief_title>Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Patients 18 year Confirmed diagnosis metastatic NSCLC Pemetrexed Starts 1st line ( either induction maintenance ) follow period : January 1 , 2010 March 31 , 2010 October 1 , 2011 December 31 , 2011 Patients receive pemetrexed within clinical trial protocol experimental environment reflect clinical practice .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>